Benzinga's Top Upgrades, Downgrades For April 24, 2018

Top Upgrades

• Susquehanna upgraded KeyCorp KEY from Neutral to Positive. KeyCorp shares rose 1.16 percent to $20.10 in pre-market trading.
• Deutsche Bank upgraded Discovery, Inc. DISCA from Hold to Buy. Discovery shares rose 3.07 percent to $24.50 in pre-market trading.
• Leerink Swann upgraded Cardinal Health, Inc. CAH from Market Perform to Outperform. Cardinal Health shares rose 0.24 percent to close at $62.22 on Monday.
• Berenberg upgraded Emerson Electric Co. EMR from Sell to Hold. Emerson Electric shares fell 0.43 percent to close at $69.90 on Monday.
• Analysts at Raymond James upgraded Cenovus Energy Inc. CVE from Underperform to Market Perform. Cenovus Energy shares fell 0.31 percent to close at $9.60 on Monday.
• Deutsche Bank upgraded Fresenius Medical Care AG & Co. KGaA FMS from Hold to Buy. Fresenius Medical shares rose 3.39 percent to $50.87 in pre-market trading.
• Goldman Sachs upgraded BP p.l.c. BP from Neutral to Buy. BP shares rose 1.14 percent to $44.42 in pre-market trading.
• Needham upgraded Cadence Design Systems, Inc. CDNS from Hold to Buy. Cadence Design shares gained 12.03 percent to $41.16 in pre-market trading.
• Loop Capital upgraded Hexcel Corporation HXL from Hold to Buy. Hexcel shares rose 0.54 percent to $65.40 in pre-market trading.

Top Downgrades

• Citigroup downgraded Alcoa Corporation AA from Buy to Neutral. Alcoa shares fell 0.56 percent to $51.62 in pre-market trading.
• Mizuho downgraded Skyworks Solutions, Inc. SWKS from Buy to Neutral. Skyworks shares fell 0.78 percent to $87.95 in pre-market trading.
• Analysts at RBC Capital downgraded Vale S.A. VALE from Outperform to Sector Perform. VALE shares rose 0.07 percent to $13.75 in pre-market trading.
• Raymond James downgraded Imperial Oil Limited IMO from Market Perform to Underperform. Imperial Oil shares rose 0.92 percent to close at $29.71 on Monday.
• Wells Fargo downgraded Dynagas LNG Partners LP DLNG from Market Perform to Underperform. Dynagas LNG Partners shares dropped 5.06 percent to $9.00 in pre-market trading.
• CL King downgraded Bojangles', Inc. BOJA from Buy to Neutral. Bojangles shares fell 0.67 percent to close at $14.80 on Monday.
• BTIG Research downgraded Prothena Corporation plc PRTA from Buy to Neutral. Prothena shares rose 1.30 percent to $11.65 in pre-market trading.
• Goldman Sachs downgraded Henry Schein, Inc. HSIC from Buy to Neutral. Henry Schein shares declined 1.34 percent to $72.80 in pre-market trading.

Top Initiations

• Wells Fargo initiated coverage on The Home Depot, Inc. HD with an Outperform rating. The price target for Home Depot is set to $205. Home Depot shares closed at $177.66 on Monday.
• Citigroup initiated coverage on iQIYI, Inc. IQ with a Buy rating. The price target for iQIYI is set to $22. iQIYI shares closed at $18.24 on Monday.
• Maxim Group assumed coverage on Applied DNA Sciences, Inc. APDN with a Buy rating. The price target for Applied DNA Sciences is set to $5. Applied DNA Sciences shares closed at $1.44 on Monday.
• Analysts at Wells Fargo initiated coverage on Lowe's Companies, Inc. LOW with an Outperform rating. The price target for Lowe's is set to $100. Lowe's shares closed at $84.35 on Monday.
• Wells Fargo initiated coverage on AutoZone, Inc. AZO with an Outperform rating. The price target for AutoZone is set to $700. AutoZone shares closed at $599.47 on Monday.
• Mizuho initiated coverage on First Data Corporation FDC with a Buy rating. The price target for First Data is set to $19. First Data shares closed at $15.14 on Monday.
• Wells Fargo initiated coverage on Best Buy Co., Inc. BBY with a Market Perform rating. The price target for Best Buy is set to $77. Best Buy shares closed at $73.50 on Monday.
• Analysts at Hovde Group initiated coverage on Nicolet Bankshares, Inc. NCBS with a Market Perform rating. Nicolet Bankshares closed at $56.88 on Monday.
• Goldman Sachs initiated coverage on Alder Biopharmaceuticals, Inc. ALDR with a Neutral rating. The price target for Alder Biopharmaceuticals is set to $17. Alder Biopharmaceuticals shares closed at $13.65 on Monday.